Terns Pharmaceuticals halts its TERN-601 obesity program due to insufficient efficacy and safety concerns. Click here to read ...
Researchers have engineered a rare type of immune cell to kill slow-growing bowel cancer cells that are resistant to current therapies.
This study presents a useful inventory of genes that are up- and down-regulated in the mouse small intestine (duodenum and ileum) during the first postnatal month; the data were collected and analyzed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback